Gov. Jay Nixon joined leadership of Pharma Medica Research, Inc. and local government and economic development officials Nov. 20 to cut the ribbon on the contract research organization’s new research facility in St. Charles. The $30.8 million project will bring 320 new high-tech jobs to the state within the next three years. The St. Charles facility will be the company’s first expansion outside of Canada. Earlier this year, Governor Nixon met with company officials at the 2013 International BIO Convention in Chicago to discuss opportunities for growth in Missouri.
“This new facility in St. Charles provides excellent opportunities for Pharma Medica Research Inc.,” said Mohammed Bouhajib of Pharma Medica Research Inc. “Here we have access to an experienced work force and booming biotech and pharmaceutical industries. By expanding here, we’re better positioned to compete and succeed in a global economy.”
This week, Missouri welcomed another bio project, as Nanova Biomaterials, Inc., (NBI), an early-stage biotech company in Columbia, announced it is expanding its operations. The company’s $1.5-million expansion project is expected to create 50 new jobs within the first five years. “Mid Missouri has been a great place to launch a tech startup,” said Dr. Hao Li, president of NBI. “Missouri’s innovative economic toolkit has made the state a go-to place for startups, and being in close proximity to the University of Missouri, a prominent research institution, we’ve had access to extensive resources and world-class talent.”
(Pictured left to right: St. Charles Mayor Sally Faith; Mohammed Bouhajib, VP of Lab Operations; Latifah Yamlahi, President & CEO of Pharma Vetmedica; Governor Jay Nixon and Mike Panayi, President Pinnacle Capital Partners.